Ananya Health

Ananya Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.6M

Overview

Ananya Health is a private, pre-revenue medical device startup founded in 2020 and based in San Francisco, focused on eliminating cervical cancer through accessible treatment. The company is developing the CRCL system, a portable, closed-loop cryoablation device intended to enable 'screen-and-treat' protocols in any clinic, addressing critical barriers in the global care cascade. Backed by non-dilutive grant funding and strategic venture investment, Ananya is advancing its technology through development and regulatory pathways with a lean, US-based team and key clinical advisors.

OncologyWomen's Health

Technology Platform

CRCL™: A portable, battery-powered, closed-loop cryoablation platform for treating pre-cancerous cervical lesions at the point of care, eliminating need for consumable gas canisters.

Funding History

2
Total raised:$1.6M
Grant$1.2M
Grant$397K

Opportunities

The global push for cervical cancer elimination, led by the WHO, creates a massive, mission-aligned market for point-of-care treatment devices.
The company's technology enables 'screen-and-treat' protocols, which can dramatically improve patient follow-up and reduce system costs, making it highly attractive to public health systems and NGOs worldwide.

Risk Factors

Key risks include failure to achieve regulatory clearance for the novel device, challenges in manufacturing and scaling a reliable product, and slow adoption in complex global health markets despite proven need.
Competition from other portable ablation technologies or simplified versions of existing treatments also poses a threat.

Competitive Landscape

Competition includes traditional gas-based cryotherapy systems (e.g., Wallach, Brymill) and other ablative techniques like thermal coagulation (e.g., Liger's Thermocoagulator). Ananya's primary differentiation is its closed-loop, portable system designed specifically to eliminate the gas supply chain, potentially offering a significant cost and logistics advantage in low-resource settings.